Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.48 |
| ▸ | FBP1 | P09467 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | CASR | P41180 | 2/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.43 |
| ▸ | AOC3 | Q16853 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.42 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.42 |
| ▸ | PRKG1 | Q13976 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.42 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.42 |
| ▸ | PRKCG | P05129 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27656326 | 0.84 | FBP1 (0.49) | MAPK1CHRM2CHRM1CHRM3FBP1 | |
| SCHEMBL188305 | 0.83 | TSHR (0.39) | MAPK1L3MBTL1SMN1; SMN2CYP3A4 | |
| SCHEMBL6283602 | 0.83 | FBP1 (0.47) | MAPK1CHRM2CHRM1CHRM3FBP1 | |
| SCHEMBL9681042 | 0.82 | ALDH1A1 (0.44) | MAPK1FBP1 | |
| SCHEMBL4297104 | 0.81 | CHRM2 (0.43) | CHRM2CHRM1CHRM3 | |
| SCHEMBL20514192 | 0.81 | MAPK1 (0.51) | MAPK1CHRM2CHRM1CHRM3FBP1 | |
| SCHEMBL19169780 | 0.81 | MAPK1 (0.51) | MAPK1CHRM2CHRM1CHRM3FBP1 | |
| SCHEMBL7455624 | 0.80 | MAPK1 (0.59) | MAPK1CHRM2CHRM1CHRM3FBP1 | |
| SCHEMBL17466751 | 0.79 | CNR1 (0.52) | MAPK1CHRM2CHRM1CHRM3FBP1 | |
| SCHEMBL3696478 | 0.79 | CNR1 (0.52) | MAPK1CHRM2CHRM1CHRM3FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1655070-B1 | OXIDATION CATALYST | ASAHI KASEI CHEMICALS CORP (JP) | 2015-07-15 | — | — | EP | disclosed |
| US-8133834-B2 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2012-03-13 | — | — | US | disclosed |
| CN-1835800-B | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2010-04-28 | — | — | CN | disclosed |
| US-20100069670-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20060229471-A1 | Oxidation catalyst | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2006-10-12 | — | — | US | disclosed |
| CN-1835800-A | Oxidation catalyst | ASAHI CHEMICAL CORP (JP) | 2006-09-20 | — | — | CN | disclosed |
| EP-1655070-A1 | OXIDATION CATALYST | Asahi Kasei Chemicals Corporation (JP) | 2006-05-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069670-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | MAPK1 2581/4885CHRM2 2600/4885CHRM1 1419/4885 |
| US-20060229471-A1 | Oxidation catalyst | PPOX, SOD1, HAO2 | MAPK1 2581/4885CHRM2 2600/4885CHRM1 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.